As usual, there is contrary information or incomplete...

As usual, there is contrary information or incomplete information causing confusion.

The number of patients anticipated in cohort three (per the chart) is two. However they are listed to be dosed in a 1+2 fashion. Which is actually three. As per the plan.

Then they say additional patients will be dosed in the higher range. They fail to mention what is going on with patient eight but also reiterate that cohort four's first patient will be dosed in December.

A great report but they have failed to be concise and have the charted figures not adding up.

Whichever way it goes I'm super confident that cohort four will slay it. Dead. Kaput.

Also..... Hoyland, I think that liver biopsies are so small and the dose so low, that any unevenness will end up exaggerated either way. I'm just a layman but I think the biopsy may be a little uncertain and inaccurate.